PCRX

Pacira BioSciences, Inc. NASDAQ

Healthcare ·Drug Manufacturers - Specialty & Generic ·US · pacira.com

$24.69

Mkt Cap $971.2M

52w Low $18.80 66.6% of range 52w High $27.64

50d MA $23.34 200d MA $23.63

P/E (TTM) 152.8x

EV/EBITDA 12.2x

P/B 1.6x

Debt/Equity 0.7x

ROE 1.0%

P/FCF 8.4x

RSI (14) —

ATR (14) —

Beta 0.20

50d MA $23.34

200d MA $23.63

Avg Volume 719.0K

About

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce control…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Apr 30, 2026	AMC	0.61	0.60	-1.6%	25.49	+5.5%	-4.1%	—	—	—	—	—	—
Feb 26, 2026	AMC	0.85	0.57	-32.9%	22.59	-6.4%	-3.0%	-5.8%	-2.2%	+1.2%	+1.2%	+3.0%	—
Nov 6, 2025	AMC	0.65	0.70	+7.7%	21.10	-3.7%	+4.5%	+9.3%	+14.3%	+13.1%	+11.9%	+15.7%	—
Aug 5, 2025	AMC	0.72	0.74	+2.8%	22.54	-1.3%	-0.6%	+5.5%	+11.7%	+11.8%	+10.1%	+18.6%	—
May 8, 2025	AMC	0.57	0.62	+8.8%	24.91	-7.7%	+0.8%	+0.7%	-6.1%	-1.8%	+2.8%	+2.0%	—
Feb 27, 2025	AMC	0.78	0.91	+16.7%	25.38	+2.4%	-5.2%	-9.5%	-7.3%	-7.4%	-6.0%	-2.1%	—
Nov 6, 2024	AMC	0.72	0.79	+9.7%	17.67	-0.5%	+0.2%	-2.4%	-1.0%	-4.9%	-6.9%	+9.1%	—
Jul 30, 2024	AMC	0.73	0.89	+21.9%	19.54	+13.6%	+5.7%	+6.2%	+8.8%	+3.3%	+10.6%	-21.4%	—
May 7, 2024	AMC	0.64	0.62	-3.1%	26.51	+9.0%	+11.8%	+12.6%	+11.0%	+14.6%	+16.3%	+9.8%	—
Feb 29, 2024	AMC	0.89	0.89	+0.0%	29.72	-0.1%	-2.9%	-1.7%	-0.9%	+1.3%	+3.1%	-1.9%	—
Nov 2, 2023	AMC	0.84	0.72	-14.3%	29.19	+2.0%	+6.3%	+5.3%	+3.7%	+2.5%	-2.6%	-2.4%	—
Aug 2, 2023	AMC	0.81	0.78	-3.7%	36.71	+2.1%	+5.6%	+7.5%	+3.9%	+4.0%	+3.7%	-3.2%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
May 1	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$25.49	$26.90	+5.5%	-4.1%	—	—	—	—
May 1	Needham	Maintains	Buy → Buy	—	$25.49	$26.90	+5.5%	-4.1%	—	—	—	—
Mar 26	Barclays	Maintains	Equal Weight → Equal Weight	—	$23.49	$23.27	-0.9%	-0.8%	-2.6%	-0.9%	-3.8%	-3.0%
Jan 9	Needham	Maintains	Buy → Buy	—	$26.02	$24.64	-5.3%	-9.6%	-11.9%	-17.0%	-14.5%	-20.6%
Jan 9	HC Wainwright & Co.	Maintains	Buy → Buy	—	$26.02	$24.64	-5.3%	-9.6%	-11.9%	-17.0%	-14.5%	-20.6%
Nov 7	Truist	Maintains	Buy → Buy	—	$21.10	$20.32	-3.7%	+4.5%	+9.3%	+14.3%	+13.1%	+11.9%
May 9	Needham	Maintains	Buy → Buy	—	$24.91	$23.00	-7.7%	+0.8%	+0.7%	-6.1%	-1.8%	+2.8%
Apr 8	Needham	Maintains	Buy → Buy	—	$22.91	$27.60	+20.5%	+14.7%	+12.8%	+3.4%	+7.2%	+9.0%
Apr 8	HC Wainwright & Co.	Maintains	Buy → Buy	—	$22.91	$27.60	+20.5%	+14.7%	+12.8%	+3.4%	+7.2%	+9.0%
Feb 28	Needham	Maintains	Buy → Buy	—	$25.38	$26.00	+2.4%	-5.2%	-9.5%	-7.3%	-7.4%	-6.0%
Feb 28	HC Wainwright & Co.	Maintains	Buy → Buy	—	$25.38	$26.00	+2.4%	-5.2%	-9.5%	-7.3%	-7.4%	-6.0%
Feb 28	Barclays	Maintains	Overweight → Overweight	—	$25.38	$26.00	+2.4%	-5.2%	-9.5%	-7.3%	-7.4%	-6.0%
Jan 30	Truist	Upgrade	Sell → Hold	—	$26.03	$27.00	+3.7%	+0.8%	+1.2%	-1.1%	+2.2%	+4.1%
Jan 14	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$21.13	$21.12	-0.0%	-2.7%	+3.5%	+4.4%	+5.8%	+8.1%
Jan 13	Needham	Maintains	Buy → Buy	—	$20.64	$21.01	+1.8%	+2.4%	-0.4%	+6.0%	+6.9%	+8.3%
Dec 17	Needham	Maintains	Buy → Buy	—	$19.87	$19.72	-0.8%	-0.2%	-3.4%	-1.5%	-4.5%	-3.4%
Dec 4	HC Wainwright & Co.	Maintains	Buy → Buy	—	$16.68	$16.71	+0.2%	+14.4%	+11.9%	+15.5%	+14.4%	+18.5%
Nov 12	Barclays	Maintains	Equal Weight → Equal Weight	—	$17.50	$17.13	-2.1%	-4.0%	-6.0%	-6.5%	-5.1%	-4.9%
Nov 8	Needham	Maintains	Buy → Buy	—	$17.70	$17.59	-0.6%	-2.6%	-1.1%	-5.1%	-7.1%	-7.5%
Nov 7	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$17.67	$17.58	-0.5%	+0.2%	-2.4%	-1.0%	-4.9%	-6.9%
Oct 4	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$15.89	$16.05	+1.0%	+4.0%	+0.6%	-1.4%	-2.0%	-2.4%
Sep 24	Jefferies	Maintains	Buy → Buy	—	$14.28	$14.45	+1.2%	-0.1%	-2.6%	+0.4%	+1.8%	+5.4%
Aug 13	Truist	Downgrade	Buy → Sell	—	$12.29	$11.55	-6.0%	+0.9%	+1.5%	+8.6%	+5.3%	+13.8%
Aug 12	HC Wainwright & Co.	Maintains	Buy → Buy	—	$11.70	$12.06	+3.1%	+5.0%	+6.0%	+6.6%	+14.1%	+10.6%
Aug 12	RBC Capital	Downgrade	Outperform → Sector Perform	—	$11.70	$12.06	+3.1%	+5.0%	+6.0%	+6.6%	+14.1%	+10.6%
Aug 12	Needham	Maintains	Buy → Buy	—	$11.70	$12.06	+3.1%	+5.0%	+6.0%	+6.6%	+14.1%	+10.6%
Aug 12	JP Morgan	Downgrade	Overweight → Underweight	—	$11.70	$12.06	+3.1%	+5.0%	+6.0%	+6.6%	+14.1%	+10.6%
Aug 1	Jefferies	Maintains	Buy → Buy	—	$20.65	$20.85	+1.0%	+0.5%	+3.0%	-2.3%	+4.6%	+8.1%
Jul 31	Needham	Maintains	Buy → Buy	—	$19.54	$22.19	+13.6%	+5.7%	+6.2%	+8.8%	+3.3%	+10.6%
Jul 31	RBC Capital	Maintains	Outperform → Outperform	—	$19.54	$22.19	+13.6%	+5.7%	+6.2%	+8.8%	+3.3%	+10.6%
Jul 31	Raymond James	Maintains	Outperform → Outperform	—	$19.54	$22.19	+13.6%	+5.7%	+6.2%	+8.8%	+3.3%	+10.6%
Jul 25	Truist	Maintains	Buy → Buy	—	$20.26	$20.23	-0.1%	-1.4%	-1.1%	+0.5%	-3.6%	+1.9%
Jul 3	Piper Sandler	Maintains	Overweight → Overweight	—	$22.74	$21.71	-4.5%	-4.7%	-7.4%	-9.4%	-7.8%	-10.6%
Jul 3	Barclays	Downgrade	Overweight → Equal Weight	—	$22.74	$21.71	-4.5%	-4.7%	-7.4%	-9.4%	-7.8%	-10.6%
Jul 2	HC Wainwright & Co.	Maintains	Buy → Buy	—	$28.46	$28.25	-0.7%	-20.1%	-23.9%	-26.0%	-27.6%	-26.4%
Jul 2	Needham	Maintains	Buy → Buy	—	$28.46	$28.25	-0.7%	-20.1%	-23.9%	-26.0%	-27.6%	-26.4%
May 8	Barclays	Maintains	Overweight → Overweight	—	$26.51	$28.90	+9.0%	+11.8%	+12.6%	+11.0%	+14.6%	+16.3%
May 8	Needham	Maintains	Buy → Buy	—	$26.51	$28.90	+9.0%	+11.8%	+12.6%	+11.0%	+14.6%	+16.3%
May 8	HC Wainwright & Co.	Maintains	Buy → Buy	—	$26.51	$28.90	+9.0%	+11.8%	+12.6%	+11.0%	+14.6%	+16.3%
Apr 9	Needham	Maintains	Buy → Buy	—	$28.48	$28.60	+0.4%	+0.1%	-2.3%	-3.9%	-5.8%	-6.8%
Mar 4	HC Wainwright & Co.	Maintains	Buy → Buy	—	$28.86	$28.40	-1.6%	+1.2%	+2.0%	+4.3%	+6.2%	+8.8%
Mar 1	Needham	Maintains	Buy → Buy	—	$29.72	$29.69	-0.1%	-2.9%	-1.7%	-0.9%	+1.3%	+3.1%
Mar 1	RBC Capital	Maintains	Outperform → Outperform	—	$29.72	$29.69	-0.1%	-2.9%	-1.7%	-0.9%	+1.3%	+3.1%
Feb 8	Wedbush	Maintains	Outperform → Outperform	—	$28.49	$28.55	+0.2%	-2.8%	+1.0%	+5.4%	+2.5%	+2.6%
Nov 6	HC Wainwright & Co.	Maintains	Buy → Buy	—	$31.04	$30.79	-0.8%	-1.0%	-2.4%	-3.6%	-8.4%	-8.2%
Nov 3	RBC Capital	Maintains	Outperform → Outperform	—	$29.19	$29.76	+2.0%	+6.3%	+5.3%	+3.7%	+2.5%	-2.6%
Nov 3	Piper Sandler	Maintains	Overweight → Overweight	—	$29.19	$29.76	+2.0%	+6.3%	+5.3%	+3.7%	+2.5%	-2.6%
Nov 3	Needham	Maintains	Buy → Buy	—	$29.19	$29.76	+2.0%	+6.3%	+5.3%	+3.7%	+2.5%	-2.6%
Oct 23	Barclays	Maintains	Overweight → Overweight	—	$28.51	$28.29	-0.8%	-1.8%	-1.0%	-4.5%	-4.3%	-3.3%
Oct 3	RBC Capital	Maintains	Outperform → Outperform	—	$29.86	$29.78	-0.3%	-2.1%	-4.0%	-2.7%	-0.2%	+1.3%

Recent Filings

8-K

Pacira BioSciences, Inc. -- 8-K Filing

Pacira BioSciences reported record-high EXPAREL sales with 7% volume growth in Q4, its strongest quarter in three years, signaling robust market demand for its flagship anesthetic product.

Feb 26

Data updated apr 26, 2026 6:58pm · Source: massive.com